Visara appoints ophthalmology leaders to advance VIS-101 drug program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. ACVA
3. SPY
4. RIOT
5. RPD
6. CRWV
7. NVDA
8. HIMS
9. FERG
10. BBIO

Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program
(NASDAQ: AURA) Delayed: 8.04 +0.34 (4.42%)
Previous Close $7.70    52 Week High $ 
Open $7.55    52 Week Low $ 
Day High $8.20    P/E N/A 
Day Low $7.31    EPS $ 
Volume 1,008,534       

(NASDAQ: FDMT) Delayed: 11.47 +0.33 (2.96%)
Previous Close $11.14    52 Week High $ 
Open $11.31    52 Week Low $ 
Day High $11.54    P/E N/A 
Day Low $10.80    EPS $ 
Volume 453,666       

(NASDAQ: NBP) Delayed: 1.84 +0.07 (3.95%)
Previous Close $1.77    52 Week High $6.95 
Open $1.78    52 Week Low $6.95 
Day High $1.85    P/E 0.86 
Day Low $1.76    EPS $2.14 
Volume 318,920